Empire Medicinals, Inc. — Form D/A
Empire Medicinals, Inc. of ROCHESTER, NY, a company, filed a Form D amendment with the SEC on 2019-03-27. The offering totals $1.0M, of which $160K was reported sold. Industry: Other.
Offering
- Filed: 2019-03-27
- Form: D/A
- Accession: 0001697880-19-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $160K
- Remaining: $840K
- Minimum investment: $10K
- Investors: 5
- Date of first sale: 2017-02-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-280932
Issuer
- Name: Empire Medicinals, Inc.
- CIK: 0001697880
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 125 TECH PARK DRIVE, ROCHESTER, NY, 14623
- Phone: 5853050095
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Christopher K Carter | Director | Rochester, NY |
| F Scott Valpey | Director | Rochester, NY |
| Qiaosong George Zheng | Director | Rochester, NY |
| Christopher K Carter | Executive Officer | Rochester, NY |
| Andrew Scott Pomeroy | Executive Officer | Rochester, NY |
| F Scott Valpey | Executive Officer | Rochester, NY |
| Qiaosong George Zheng | Executive Officer | Rochester, NY |
Other filings by this issuer (1)
More